MODERNA GETS $50 MILLION TO DEVELOP MRNA EBOLA VACCINE AGAINST BUNDIBUGYO

Summary from the TLDR newsletter

The Coalition for Epidemic Preparedness Innovations (CEPI) has pledged a little over $60 million to accelerate the development of three vaccine candidates against the Bundibugyo ebolavirus (BDBV). There are currently two licensed vaccines against Ebola, but they both target a different strain. The lack of medical interventions is allowing the virus to spread out of control in the Democratic Republic of the Congo. The disease is spreading in an area with armed conflict, large population mobility, and significant need for humanitarian assistance.